147 related articles for article (PubMed ID: 34482472)
1. Indolent T-lymphoblastic proliferation: a report of three cases.
Yuanyuan Z; Jianlan X; Yanlin Z; Xiaoge Z
Virchows Arch; 2022 May; 480(5):1121-1126. PubMed ID: 34482472
[TBL] [Abstract][Full Text] [Related]
2. Indolent T-lymphoblastic proliferation (iT-LBP): a review of clinical and pathologic features and distinction from malignant T-lymphoblastic lymphoma.
Ohgami RS; Arber DA; Zehnder JL; Natkunam Y; Warnke RA
Adv Anat Pathol; 2013 May; 20(3):137-40. PubMed ID: 23574769
[TBL] [Abstract][Full Text] [Related]
3. Indolent T-lymphoblastic proliferation concomitant with acinic cell carcinoma mimicking T-lymphoblastic lymphoma: case report and literature review.
Yasuda H; Tsutsui M; Ota Y; Tanaka M; Komatsu N
Histopathology; 2018 Apr; 72(5):862-866. PubMed ID: 29143359
[TBL] [Abstract][Full Text] [Related]
4. LIM domain only 2 (LMO2) expression distinguishes T-lymphoblastic leukemia/lymphoma from indolent T-lymphoblastic proliferations.
Brar N; Butzmann A; Kumar J; Peerani R; Morgan EA; Grigoriadis G; Kumar B; Tatarczuch RM; Warnke RA; Ohgami RS
Histopathology; 2020 Dec; 77(6):984-988. PubMed ID: 32526041
[TBL] [Abstract][Full Text] [Related]
5. TdT+ T-lymphoblastic populations are increased in Castleman disease, in Castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblastic T-cell lymphoma.
Ohgami RS; Zhao S; Ohgami JK; Leavitt MO; Zehnder JL; West RB; Arber DA; Natkunam Y; Warnke RA
Am J Surg Pathol; 2012 Nov; 36(11):1619-28. PubMed ID: 23060347
[TBL] [Abstract][Full Text] [Related]
6. Indolent T-lymphoblastic proliferation with disseminated multinodal involvement and partial CD33 expression.
Ohgami RS; Sendamarai AK; Atwater SK; Liedtke M; Fleming MD; Natkunam Y; Warnke RA
Am J Surg Pathol; 2014 Sep; 38(9):1298-304. PubMed ID: 24618611
[TBL] [Abstract][Full Text] [Related]
7. Indolent T-lymphoblastic proliferation with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma: a case report.
Han W; Wang B; Yong X; Zhang Y; Shao M; Wang C
Pathol Oncol Res; 2023; 29():1611151. PubMed ID: 37252318
[No Abstract] [Full Text] [Related]
8. Follicular Dendritic Cell Sarcoma With Indolent T-Lymphoblastic Proliferation Is Associated With Paraneoplastic Autoimmune Multiorgan Syndrome.
Walters M; Pittelkow MR; Hasserjian RP; Harris NL; Macon WR; Kurtin PJ; Rech KLG
Am J Surg Pathol; 2018 Dec; 42(12):1647-1652. PubMed ID: 30222603
[TBL] [Abstract][Full Text] [Related]
9. Exuberant cortical thymocyte proliferation mimicking T-lymphoblastic lymphoma within recurrent large inguinal lymph node masses of localized Castleman disease.
Kansal R; Nathwani BN; Yiakoumis X; Moschogiannis M; Sachanas S; Stefanaki K; Pangalis GA
Hum Pathol; 2015 Jul; 46(7):1057-61. PubMed ID: 25953658
[TBL] [Abstract][Full Text] [Related]
10. Indolent T-Lymphoblastic Proliferation in Idiopathic Multicentric Castleman Disease.
Karki NR; Arfa AS; Savage N; Kutlar A
Acta Haematol; 2022; 145(2):214-220. PubMed ID: 34818661
[TBL] [Abstract][Full Text] [Related]
11. Indolent T-lymphoblastic proliferation involving hepatocellular carcinoma-presentation in novel settings and comprehensive review of literature.
Ghezavati A; Liang CA; Mais D; Nazarullah A
J Hematop; 2023 Sep; 16(3):167-175. PubMed ID: 38175402
[TBL] [Abstract][Full Text] [Related]
12. Indolent T-lymphoblastic proliferation associated with Castleman disease and low grade follicular dendric cell sarcoma: report of a case and review of literature.
Chen J; Feng J; Xiao H; Ma Q; Chen Z
Int J Clin Exp Pathol; 2019; 12(4):1497-1505. PubMed ID: 31933967
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic significance of lymph node core needle biopsy for lymphoproliferative disease: a clinicopathologic study of 1 013 cases].
Huang RF; Zhang WY; Liu WP; Zhao S; Ye YX; Sun H; Gao LM; Wang JC; Yang QP
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):19-24. PubMed ID: 29325246
[No Abstract] [Full Text] [Related]
14. Benign lymphoid disorders of the lung, with a theory regarding their development.
Kradin RL; Mark EJ
Hum Pathol; 1983 Oct; 14(10):857-67. PubMed ID: 6352457
[TBL] [Abstract][Full Text] [Related]
15. Indolent T-lymphblastic proliferation: report of a case involving the upper aerodigestive tract.
Yang F; Liu T; Zhao H; Hu Z; Xiao L; Liu Y; Wang X; Li Z
Int J Clin Exp Pathol; 2014; 7(9):6350-6. PubMed ID: 25337290
[TBL] [Abstract][Full Text] [Related]
16. T cell-rich lymphoid infiltrates with large B cells: a review of key entities and diagnostic approach.
Cheng CL; O'Connor S
J Clin Pathol; 2017 Mar; 70(3):187-201. PubMed ID: 27895166
[TBL] [Abstract][Full Text] [Related]
17. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.
Sheibani K; Winberg CD; van de Velde S; Blayney DW; Rappaport H
Am J Pathol; 1987 Apr; 127(1):27-37. PubMed ID: 3105322
[TBL] [Abstract][Full Text] [Related]
18. Bcl-6 expression in reactive follicular hyperplasia, follicular lymphoma, and angioimmunoblastic T-cell lymphoma with hyperplastic germinal centers: heterogeneity of intrafollicular T-cells and their altered distribution in the pathogenesis of angioimmunoblastic T-cell lymphoma.
Ree HJ; Kadin ME; Kikuchi M; Ko YH; Suzumiya J; Go JH
Hum Pathol; 1999 Apr; 30(4):403-11. PubMed ID: 10208461
[TBL] [Abstract][Full Text] [Related]
19. Histological diversity of reactive and atypical proliferative lymph node lesions in systemic lupus erythematosus patients.
Kojima M; Motoori T; Asano S; Nakamura S
Pathol Res Pract; 2007; 203(6):423-31. PubMed ID: 17540509
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric features of incidental indolent T lymphoblastic proliferations.
Fromm JR; Edlefsen KL; Cherian S; Wood BL; Soma L; Wu D
Cytometry B Clin Cytom; 2020 May; 98(3):282-287. PubMed ID: 31571375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
